Clinical Trial Update: Pomalidomide or Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pomalidomide or lenalidomide with dexamethasone in relapsed or refractory multiple myeloma previously treated with lenalidomide complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-08-21